Tratamiento regenerativo con células madre mesenquimales provenientes de la gelatina de Wharton de cordón umbilical en la úlcera crónica por dermolipectomía

Translated title of the contribution: Regenerative treatment with umbilical cord mesenchymal stem cells from Wharton’s jelly in chronic ulcer caused by dermolipectomy

César M. Mejía-Barradas, Jaime E. Cázares-Montañez, Ángel Guerra-Márquez, Víctor G. Hernández-Chávez, Julio R. Cáceres-Cortés, Gisela Gutiérrez-Iglesias

    Research output: Contribution to journalArticlepeer-review

    3 Scopus citations

    Abstract

    Background: Procedures to remove adiposities and skin, such as dermolipectomy, can develop wounds that are difficult to heal by conventional therapies. Mesenchymal stem cells are indicated as potential candidates for regenerative therapy in wounds, due to their multipotentiality, low immunogenicity, modulating capacity of inflammation and tissue modeling processes. Case report: Patient with dehiscent chronic ulcer secondary to dermolipectomy, who received cutaneous treatment with mesenchymal stem cells. The therapy induced scar formation and neovascularization, as well as the decrease of infiltrated leukocytes and proinflammatory cytokines. Mesenchymal cells are proposed as an interesting alternative for the treatment of postoperative lesions.

    Translated title of the contributionRegenerative treatment with umbilical cord mesenchymal stem cells from Wharton’s jelly in chronic ulcer caused by dermolipectomy
    Original languageSpanish
    Pages (from-to)8-16
    Number of pages9
    JournalCirugia y Cirujanos (English Edition)
    Volume87
    DOIs
    StatePublished - 1 Jan 2019

    Fingerprint

    Dive into the research topics of 'Regenerative treatment with umbilical cord mesenchymal stem cells from Wharton’s jelly in chronic ulcer caused by dermolipectomy'. Together they form a unique fingerprint.

    Cite this